Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223262
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2005-09-15
Brief Title:
Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if lamotrigine therapy is associated with improvement in mood memory and hippocampal size and function in patients receiving chronic corticosteroid therapy Standard care for mood changes associated with corticosteroid therapy if severe includes antidepressants or other medications which can influence mood No therapies other than dose reduction or discontinuation are currently available for memory loss associated with corticosteroid treatment However very little information is available on the treatment of either mood or memory changes associated with corticosteroid treatment thus the proposed project may improve standard care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None